Literature DB >> 20599669

The bone and the kidney.

Sandro Mazzaferro1, Marzia Pasquali, Giuliana Pirrò, Silverio Rotondi, Lida Tartaglione.   

Abstract

Renal tubular diseases may present with osteopenia, osteoporosis or osteomalacia, as a result of significant derangements in body electrolytes. In case of insufficient synthesis of calcitriol, as in renal failure, the more complex picture of renal osteodystrophy may develop. Hypothetically, also disturbed renal production of BMP-7 and Klotho could cause bone disease. However, the acknowledgment that osteocytes are capable of producing FGF23, a phosphaturic hormone at the same time modulating renal synthesis of calcitriol, indicates that it is also bone that can influence renal function. Importantly, a feed-back mechanism exists between FGF23 and calcitriol synthesis, while Klotho, produced by the kidney, determines activity and selectivity of FGF23. Identification of human diseases linked to disturbed production of FGF23 and Klotho underlines the importance of this new bone-kidney axis. Kidney and bone communicate reciprocally to regulate the sophisticated machinery responsible for divalent ions homeostasis and for osseous or extraosseous mineralisation processes.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599669     DOI: 10.1016/j.abb.2010.06.028

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  10 in total

1.  Klotho deficiency disrupts hematopoietic stem cell development and erythropoiesis.

Authors:  Sangeetha Vadakke Madathil; Lindsay M Coe; Carla Casu; Despina Sitara
Journal:  Am J Pathol       Date:  2014-01-08       Impact factor: 4.307

2.  Bone in CKD: why the ERA EDTA CKD-MBD working group organized a dedicated meeting?

Authors:  Sandro Mazzaferro; Ziad A Massy; Marc Vervloet; Mario Cozzolino
Journal:  J Nephrol       Date:  2017-10       Impact factor: 3.902

Review 3.  Fibroblast Growth Factor 23: Mineral Metabolism and Beyond.

Authors:  Alexander Grabner; Sandro Mazzaferro; Giuseppe Cianciolo; Stefanie Krick; Irene Capelli; Silverio Rotondi; Claudio Ronco; Gaetano La Manna; Christian Faul
Journal:  Contrib Nephrol       Date:  2017-05-23       Impact factor: 1.580

Review 4.  Secreted klotho and chronic kidney disease.

Authors:  Ming Chang Hu; Makoto Kuro-o; Orson W Moe
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

5.  Changes in frailty-related characteristics of the hip fracture population and their implications for healthcare services: evidence from Quebec, Canada.

Authors:  M Auais; S Morin; L Nadeau; L Finch; N Mayo
Journal:  Osteoporos Int       Date:  2013-06-07       Impact factor: 4.507

6.  Effects of cyclosporin-a on rat skeletal biomechanical properties.

Authors:  Yixin Chen; Xin Zheng; Rui Zou; Junfei Wang
Journal:  BMC Musculoskelet Disord       Date:  2011-10-24       Impact factor: 2.362

Review 7.  Positioning novel biologicals in CKD-mineral and bone disorders.

Authors:  Lida Tartaglione; Marzia Pasquali; Silverio Rotondi; Maria Luisa Muci; Adrian Covic; Sandro Mazzaferro
Journal:  J Nephrol       Date:  2017-05-24       Impact factor: 4.393

8.  Interactions of sclerostin with FGF23, soluble klotho and vitamin D in renal transplantation.

Authors:  Lida Tartaglione; Marzia Pasquali; Silverio Rotondi; Maria Luisa Muci; Cristiana Leonangeli; Alessio Farcomeni; Valeria Fassino; Sandro Mazzaferro
Journal:  PLoS One       Date:  2017-05-30       Impact factor: 3.240

9.  Insights into the osteoblast precursor differentiation towards mature osteoblasts induced by continuous BMP-2 signaling.

Authors:  Omar F Zouani; Lila Rami; Yifeng Lei; Marie-Christine Durrieu
Journal:  Biol Open       Date:  2013-07-03       Impact factor: 2.422

Review 10.  Vascular Calcification-New Insights Into Its Mechanism.

Authors:  Sun Joo Lee; In-Kyu Lee; Jae-Han Jeon
Journal:  Int J Mol Sci       Date:  2020-04-13       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.